Loading...
OTCM
VIVE
Market cap9kUSD
Dec 05, Last price  
0.00USD
1D
800.00%
1Q
800.00%
Jan 2017
-99.98%
Name

Viveve Medical Inc

Chart & Performance

D1W1MN
OTCM:VIVE chart
P/E
—
P/S
0.00
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
35.28%
Revenues
6m
+17.28%
8,838,0008,334,0007,573,0007,636,0007,146,0006,004,0005,330,0004,711,0003,910,000671,0001,080,0001,274,00090,0001,447,0007,141,00015,288,00018,517,0006,567,0005,479,0006,426,000
Net income
-23m
L+7.46%
305,000517,000-833,000-1,268,0001,319,000-2,367,000-1,940,000-1,626,000-505,000-5,758,000-8,387,0003,499,000-6,180,000-12,426,000-20,111,000-36,630,000-49,182,000-46,719,000-21,239,000-22,824,000
CFO
-13m
L-15.47%
937,000607,0003,358,000-127,000494,000-1,803,000-2,968,000-2,373,000-1,346,000-3,393,000-3,165,000-4,804,000-5,991,000-12,195,000-18,087,000-34,853,000-43,090,000-31,236,000-15,234,000-12,878,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
URL
https://us.viveve.com/
IPO date
Mar 03, 1992
Employees
47
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT